Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 10, 2026 | BCBS Illinois | Airway Clearance Devices | Criteria changed |
| May 10, 2026 | BCBS Illinois | Aflibercept and Associated Biosimilar(s) | Criteria changed |
| May 10, 2026 | BCBS Illinois | Adoptive Immunotherapy | Criteria changed |
| May 10, 2026 | BCBS Illinois | Adjustable Cranial Orthoses for Positional Plagiocephaly and Craniosynostoses | Criteria changed |
| May 10, 2026 | BCBS Illinois | Adipose-Derived Stem Cells in Autologous Fat Grafting to the Breast | Criteria changed |
| May 10, 2026 | BCBS Illinois | Actigraphy | Criteria changed |
| May 10, 2026 | BCBS Illinois | Absorbable Nasal Implant for Treatment of Nasal Valve Collapse | Criteria changed |
| May 10, 2026 | BCBS Illinois | Ablation of Peripheral Nerves to Treat Pain | Criteria changed |
| May 10, 2026 | BCBS Illinois | Abatacept | Criteria changed |
| May 9, 2026 | Noridian Healthcare Solutions | Facet Joint Interventions for Pain Management | Metadata changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Phenotypic Biomarker Detection in Circulating Tumor Cells | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Repeat Germline Testing | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Prometheus® IBD sgi Diagnostic® Policy | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Plasma-Based Genomic Profiling in Solid Tumors | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Pigmented Lesion Assay | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Pharmacogenomics Testing | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Healthâ¢) | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: NRAS Genetic Testing | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Molecular Testing for Solid Organ Allograft Rejection | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Next-Generation Sequencing for Solid Tumors | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Minimal Residual Disease Testing for Cancer | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: MGMT Promoter Methylation Analysis | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Melanoma Risk Stratification Molecular Testing | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Inivataâ¢, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: HLA-DQB1*06:02 Testing for Narcolepsy | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Genetic Testing for Heritable Thoracic Aortic Disease | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Envisiaâ¢, Veracyteâ¢, Idiopathic Pulmonary Fibrosis Diagnostic Test | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: EndoPredict® Breast Cancer Gene Expression Test | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: DecisionDx-UM (Uveal Melanoma) | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Breast Cancer Index® (BCI) Gene Expression Test | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Breast Cancer Assay: Prosigna® | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Blood Product Molecular Antigen Typing | Codes changed |
| May 9, 2026 | Noridian Healthcare Solutions | MolDX: Biomarkers in Cardiovascular Risk Assessment | Codes changed |